Identification of novel glucocorticoid receptor-regulated genes involved in epidermal homeostasis and hair follicle differentiation by Donet, Eva et al.
Accepted Manuscript
Title: Identification of novel glucocorticoid receptor-regulated
genes involved in epidermal homeostasis and hair follicle
differentiation
Authors: Eva Donet, Pilar Bayo, Ezequiel Calvo, Fernand
Labrie, Paloma Pe´rez
PII: S0960-0760(07)00231-2
DOI: doi:10.1016/j.jsbmb.2007.05.033
Reference: SBMB 2944
To appear in: Journal of Steroid Biochemistry & Molecular Biology
Received date: 9-1-2007
Accepted date: 4-5-2007
Please cite this article as: E. Donet, P. Bayo, E. Calvo, F. Labrie, P. Pe´rez, Identification of
novel glucocorticoid receptor-regulated genes involved in epidermal homeostasis and
hair follicle differentiation, Journal of Steroid Biochemistry and Molecular Biology
(2007), doi:10.1016/j.jsbmb.2007.05.033
This is a PDF file of an unedited manuscript that has been accepted for publication.
As a service to our customers we are providing this early version of the manuscript.
The manuscript will undergo copyediting, typesetting, and review of the resulting proof
before it is published in its final form. Please note that during the production process
errors may be discovered which could affect the content, and all legal disclaimers that
apply to the journal pertain.
Ac
ce
pte
d M
an
us
cri
pt
 1
 
 
Identification of novel glucocorticoid receptor-regulated genes involved in epidermal 
homeostasis and hair follicle differentiation 
 
Eva Donet (1,2), Pilar Bayo (1,2), Ezequiel Calvo (3), Fernand Labrie (3) and Paloma Pérez (1,2,*) 
(1) Centro de Investigación Príncipe Felipe CIPF, Av. Autopista del Saler 16, Camino de las 
Moreras, E-46013 Valencia (Spain) 
(2) Instituto de Biomedicina de Valencia IBV-CSIC, Jaime Roig 11, E-46010 Valencia 
(Spain) 
(3) Oncology and Molecular Endocrinology Research Center, Laval University Medical 
Center (CHUL) and Laval University, Quebec, G1V 4G2, Canada 
 
* Corresponding author: Paloma Pérez. Centro de Investigación Príncipe Felipe and 
Instituto de Biomedicina de Valencia (CSIC) 
* To whom reprint requests should be addressed 
Address correspondence: Paloma Pérez, Centro de Investigación Príncipe Felipe, Valencia, 
Av. Autopista del Saler 16, Camino de las Moreras, E-46013-Valencia, Spain. 
Tel +34 96 328 9680 
Fax +34 96 328 9701 
pperez@cipf.es 
Running title: Novel genes regulated by glucocorticoids in skin 
Keywords: glucocorticoid receptor, epidermal homeostasis, microarray analysis, transgenic 
mice 
Page 1 of 32 
Ac
ce
pte
d M
an
us
cri
pt
 2
 
Abstract 
Despite that glucocorticoids (GCs), acting through the glucocorticoid receptor (GR) exert a 
pivotal role in skin physiopathology, specific genes regulated by GR in this tissue are 
largely unknown. We have used a transgenic mouse model overexpressing GR in epidermal 
basal cells and outer root sheath (ORS) of the hair follicle (HF) under the control of the 
keratin 5 regulatory sequences (K5-GR mice) to identify GR-regulated genes in mouse 
skin. We analyzed the transcriptomic profile of adult K5-GR skin as compared to non-
transgenic adult mice by using oligonucleotide microarrays and identified 173 genes 
differentially regulated by GR in this tissue. Our data were further validated by 
semiquantitative RT-PCR and quantitative real-time PCR. We have identified a large 
subset of hair keratin intermediate filament (krt) and hair keratin-associated protein (krtap) 
genes, as well as several hox genes as GC-regulated. Since dysregulation of krt, krtaps and 
hox genes can cause hair disorders, as it occurs in adult K5-GR mice, our findings strongly 
suggest a role of GR in HF morphogenesis through the coordinated regulation of these hair-
specific genes. In addition, we found that GR repressed several genes related to cell growth, 
such as the immediate early genes fosb and c-fos, according to the antiproliferative role 
described for this hormone receptor. By using cultured keratinocytes treated with GR-
agonists and -antagonists, we demonstrated that down-regulation of fosb is mediated by 
GR. Identification of novel GR-regulated genes will help us to better understand the role of 
GCs as physiological modulators and pharmacological agents. 
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Introduction 
Glucocorticoid hormones (GCs) effects are mediated through the glucocorticoid receptor 
(GR), which acts through the so-called genomic and non-genomic actions exerting 
pleiotropic roles in many tissues (reviewed in [1]). Genomic actions of GR occur in the 
nucleus through binding of the ligand-activated receptor to multicomponent protein–DNA 
complexes assembled at response elements proximal to target promoters. Transcriptional 
regulation exerted by GR is dictated by the sequence of a given glucocorticoid response 
element (GRE), its organization within the chromatin and the activities of regulatory factors 
in a particular tissue. GR can regulate gene expression through DNA-binding-dependent 
and -independent mechanisms. The former requires ligand-induced dimerization of GR and 
binding to specific GREs, whereas the latter does not require DNA-binding of GR, but 
rather is mediated through interference with other transcription factors, such as NF-κB or 
AP-1 [2]. Nongenomic actions of GR have been recently demonstrated and are due to 
physical interaction of the receptor at the plasma membrane with the p85α regulatory 
subunit of the PI3K which, in turn, modulates AKT activity [3]. 
In skin, GCs have an enormous physiological and pharmacological relevance; 
however, specific genes regulated by GR in this tissue are still undeciphered. GCs are 
potent inhibitors of epidermal proliferation and effective antiinflammatory compounds, 
which explain that GC analogues are the most prescribed agents for many skin disorders 
undergoing with hyperproliferation and inflammation [4]. However, studying the impact of 
GR in skin development has been difficult since GR null mice die perinatally [5]; mice 
carrying a DNA-binding defective mutant of GR (GR dim) are viable and they show no 
overt skin phenotype [6]. 
Page 3 of 32 
Ac
ce
pte
d M
an
us
cri
pt
 4
In mammals, the epidermis is a stratified epithelium, able to self renew under both 
homeostatic and injury conditions by maintaining a population of mitotically active cells in 
the basal epidermal layer and hair follicles (HF) (reviewed in [7]). A major function of the 
epidermis is to act as a barrier that preserves the organism from potentially environmental 
damage. Acquisition of a competent barrier occurs during embryonic development and it is 
achieved through a correct balance between proliferation and differentiation. The process of 
differentiation implies that basal keratinocytes cease to proliferate, lose adherence to the 
basement membrane and migrate to outer layers called spinous, granular and cornified 
envelope. Thus, alterations in the processes of keratinocyte proliferation and differentiation 
may lead to a disturbed epidermal barrier, which will result in dehydration, uncontrolled 
thermoregulation and augmented susceptibility to infection, often causing skin disorders of 
keratinization and cornification (reviewed in [8]). So far, contradicting reports have 
described either a positive or a negative role of GR in regulating epidermal differentiation 
and epidermal barrier formation [8]. On one hand, GR has been reported to play a relevant 
role in the process of barrier acquisition in utero since GC injections accelerated barrier 
formation and, conversely, corticotropin-releasing hormone-deficient newborn mice 
exhibiting GC deficiency, had delayed maturation of the stratum corneum. In these mice, 
supplementation of GCs fully rescued skin phenotype [9]. On the other hand, short-term 
topical and systemic GC treatment to adult mouse skin disturbed epidermal barrier 
competence [10], mimicking the effects induced by psychological stress, which is likely 
mediated by increased endogenous GCs [11]. 
Our recent work has allowed the study of GR function in skin physiopathology by 
analyzing transgenic mice that overexpress GR in epidermal basal cells, outer root sheath 
(ORS) of the hair follicle (HF), and other stratified epithelia, under the control of the 
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keratin K5 regulatory sequences (K5-GR mice) [12]. Adult K5-GR mice showed epidermal 
hypoplasia and an average decrease of 50% in the number of HFs, as compared with wt 
mice, as well as dysplastic HFs and orphan hyperplasic sebaceous glands [13]. This mouse 
phenotype is in agreement with the reported skin atrophy and HF dysplasia that occurs in 
human skin upon topical application of GC analogues, thus representing an excellent 
animal model for studying the underlying mechanisms of GR action. In this work, we 
aimed to identify gene regulated by GR in skin by comparing the gene exp ession profile of 
adult K5-GR transgenic mice and non-transgenic mice. We have found 173 genes that are 
differentially regulated in K5-GR skin, of which some are known targets of GCs and, 
importantly, we have identified for the first time a large number of novel GR-regulated 
genes involved in keratinocyte proliferation and differentiation as well as HF development. 
Altogether, the identification of several hair keratins (krts), hair keratin-associated proteins 
(krtaps) and hox as GR-regulated genes, among others, strongly suggests a role of GR in 
HF morphogenesis through the coordinated regulation of these hair-specific genes. 
Concomitant with enhanced differentiation, GR inhibited keratinocyte proliferation through 
repression of genes, such as the immediate early genes fosb and c-fos. We also 
demonstrated that down-regulation of fosb is receptor-mediated in cultured keratinocytes 
and in vivo. 
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Materials and methods 
Animals and treatments 
Animal experimentation was always conducted with accepted standards of humane 
animal care in our registered animal facility (CV-46007, Centro de Investigación Príncipe 
Felipe) in accordance with current Spanish and European normative which governs research 
with animals (Real Decreto 1201/2005, B.O.E. #252, 10 of October, 2005 and Convenio 
Europeo 1-2-3 del 18/3/1986). 
K5-GR hemizygous mice of line 285 (C57Bl/6J x DBA) F1 mixed genetic 
background) have been previously reported [12]. Mice were housed in micro isolated boxes 
in which the air is filtered in both directions, allowing maximum isolation. Transgenic mice 
for these studies were generated by mating heterozygous K5-GR mice with wild-type (wt) 
mice, thus obtaining 50% of transgenic and 50% of non-transgenic progeny. 
For gene expression profiling experiments, dorsal skin from K5-GR transgenic (n= 
6) and non-transgenic male (n= 6) adult littermates (10-wk old) was used. Collection of 
mouse skin (1 x 1 cm) was performed in anesthetized mice that had been shaved 48 h 
before with a razor blade to avoid skin irritation. The piece of skin was then rapidly frozen 
in liquid nitrogen and kept at -80ºC until RNA extraction. Three animals of each genotype 
were pooled and RNA samples were used for the microarrays by duplicate. For semi-
quantitative RT-PCR, an independent experiment was performed using RNA from dorsal 
skin of K5-GR transgenic (n= 4) and non-transgenic male (n= 4) adult littermates (10-wk 
old). 
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Cell culture and treatments 
PB keratinocytes were grown in Dulbecco´s modified Eagle´s medium (BioWhitakker, Inc., 
Walkersville, MD) supplemented with 10% fetal calf serum (FCS, BioWhitakker, Inc.). For 
experiments, cells were starved in 0.1% FCS for 16h, then treated for 8h with either 
vehicle, Dex (Sigma, St. Louis, MO) 10 nM or 1 µM, or with Dex 1 µM plus Ru486 
(BioMol) 10 µM. After that time, cells were stimulated with 20% FCS for 30 min.. 
Experiments were performed in triplicate and mean value ± SD estimated. 
 
RNA preparation 
Total RNA was isolated by using Trizol reagent (Invitrogen, Molecular Probes, Eugene, 
Oregon), following manufacturer´s recommendations and its quality was determined using 
the Nano 6000 Chip in the Bioanalyzer from Agilent Technologies, Inc. (Palo Alto, CA). 
 
Gene Expression Profiling, Identification of Regulated Genes and Statistical Analysis 
Experiments were performed by duplicate by using pooled RNA from K5-GR transgenic 
mice and wt littermates. Total RNA (10 µg) was used for cDNA synthesis according to the 
Affymetrix manual. Hybridization to GeneChips MOE 430 v2.0 arrays representing 45,101 
transcripts and Expressed Sequence Tags (EST) followed by probing and scanning was 
performed according to the Affymetrix manual. The background subtraction and 
normalization of probe set intensities was performed using the method of Robust 
Multiarray Analysis (RMA) described by Irizarry et al. [14]. To identify differentially 
expressed genes, gene expression intensity was compared using a moderated t test and a 
Bayes smoothing approach developed for a low number of replicates [15]. To correct for 
Page 7 of 32 
Ac
ce
pte
d M
an
us
cri
pt
 8
the effect of multiple testing, the false discovery rate, was estimated from p values derived 
from the moderated t test statistics [16]. The analysis was performed using the affylmGUI 
Graphical User Interface for the limma microarray package [17]. Genes were considered to 
be significantly differentially expressed if p-values were < 0.05 (controlling the expected 
false discovery rate to no more than 5%). Under these conditions, a minimal mean ratio of 
1.4-fold was used as threshold for GR-dependent induced or repressed genes. 
 
Semiquantitative RT-PCR 
Reverse transcription was performed by using 1 µg of RNA and oligo-dT (Fermentas Inc., 
Burlington, Canada) followed by PCR using specific oligonucleotides for krtap14 
(forward: 5´- GAT GTG GTA CCC CTA CTT TCT-3´; reverse: 5´-GTT TTG CCA ATT 
ACA GGA ACT C-3´), krtap16-7 (forward: 5´-TGT GCT GCA ACT ACT ACG G-3´; 
reverse: 5´-GCC ATA TCC ACA GCC ATA T-3´), krtap16-8 (forward: 5´-CTA TGG 
CTG TGG CTA CCG-3´; reverse: 5´-ACA TGC AGT TCA GAA TTG GAG-3´), Gprc5d 
(forward: 5´-CAA ACT GCC CCT GTT CGC TAC TTC-3´; reverse: 5´-GAC CTG TAG 
AGT ATG CTC AGC TCA-3´) and fosb (forward: 5´-AGC TGT TGA CCC TTA TGA 
CAT G-3´; reverse: 5´-CGC CGA GGA CTT GAA CTT CAC TGT-3´). To achieve 
semiquantitative amplification, 25 cycles were used; bands corresponding to specific PCR 
products were quantitated by using Image Gauge Software (Fuji Photo Film, USA, Inc., 
Edison, NJ). 
 
Quantitative RT-PCR 
Page 8 of 32 
Ac
ce
pte
d M
an
us
cri
pt
 9
Oligoprimer pairs were designed by GeneTools software (Biotools Inc, Edmonton, Alberta, 
Canada) and their specificity was verified by blast in the GenBank database. Briefly, after 
Dnase1 treatment of total RNA and purification (Rneasy MinEluate Cleanup, QIAGEN) to 
remove contamination of genomic DNA, RNA quality was assessed (Bioanalyzer, 
AGILENT) and cDNA synthesis performed by reverse transcriptase. 
cDNA corresponding to 20 ng of total RNA was used  to perform fluorescent-based 
Realtime PCR quantification using the LightCycler Realtime PCR apparatus (Roche 
Inc.(Nutley, NJ). Reagents were obtained from the same company and were used as 
described by the manufacturer. The conditions for PCR reactions were: denaturation at 
95°C for 10 sec, annealing at 56 to 66°C for 5 sec and elongation at 72°C for 7 to 13 sec. 
The reaction was then heated for 3 sec at 2°C lower than the melting temperature of the 
DNA fragment. Reading of the fluorescence signal was taken at the end of the heating to 
avoid non-specific signal. A melting curve was performed to assess non-specific signal. 
Data calculation and normalization was performed using second derivative and double 
correction method [18] and using the housekeeping genes hypoxanthine guanine 
phosphoribosyl transferase 1 (Hprt1) and ATP synthase O subunit (Atp5o). Hprt1 and 
Atp5o have shown to be genes having stable expression levels from embryonic life through 
adulthood in various tissues [18]. mRNA expression levels are expressed as ratio of 
(gene/housekeeping)transgenic / (gene/housekeeping)wt.  
The following genes were evaluated by q-RT-PCR: c-fos (FBJ osteosarcoma 
oncogene, 1423100_at); fosb (FBJ osteosarcoma oncogene B, 1422134_at); cyr 61 
(cysteine rich protein 61, 1442340_x_at); krt2-10 (keratin complex 2, basic, gene 10, 
1427365_at) and S100a3 (S100 calcium binding protein A3, 1421856_at). 
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Results 
Despite the pivotal role of GCs in skin physiopathology, specific genes regulated by 
of GR in this tissue are largely unknown. To identify GR-regulated genes in mouse skin, 
we have compared the transcriptome of a transgenic mouse model overexpressing GR 
under the control of the keratin 5 regulatory sequences (K5-GR mice, [12]) versus non-
transgenic mice. We isolated total RNA from dorsal skin of K5-GR transgenic and non-
transgenic adult mice (10-wk old) and, after reverse transcription, the cDNAs were 
hybridized to GeneChips MOE 430 v2.0 oligonucleotide arrays (Affymetrix, 
www.affymetrix.com) which represent over 39,000 transcripts and Expressed Sequence 
Tags (EST). Microarray data revealed 173 genes or EST sequences that were significantly 
up- (50.9%) or down-regulated (49.1%) in K5-GR skin. Of all regulated genes, 31.8% were 
either not annotated or clones that represented the same gene. We have focused this study 
on mRNAs coding for known genes. The complete list of genes is under Supplemental 
information. Table 1 shows the classification of up- or down-regulated genes into 7 
functional categories, according to their Gene Ontology annotation. Although genes were 
categorized based on protein function, many of these genes likely fit into more than one 
category.  
Given that microarray data are not really quantitative, we aimed to validate our 
results by performing both semi-quantitative PCR and quantitative real-time-PCR (q-RT-
PCR, Table 2). For this purpose, we performed an independent experiment using RNA 
obtained from a different set of non- transgenic and transgenic animals (n= 4 of each 
genotype) sex- and age-matched to reproduce the experimental groups used for the 
microarrays. Table 2 shows duplicate samples of up- and down-regulated genes analyzed 
by semi-quantitative PCR using specific oligonucleotides for krtap 14, krtap16-7, krtap16-
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8, Gprc5d and fosb. In addition, we performed q-RT-PCR to quantitate the transcript levels 
of another subset of positive- and negative-regulated genes in K5-GR skin. Our data 
confirmed that krt2-10/krt86 and S100a3 were up-regulated by GR whereas c-fos, fosb and 
cyr61 were validated as down-regulated by GR (Table 2). Overall, our results demonstrate 
an excellent correlation between data obtained by the microarray experiment and semi-
quantitative PCR and q-RT-PCR methods performed in an independent experiment. 
A large proportion of genes identified in this microarray analysis (26.6% of total 
and 52.3% of the up-regulated genes), belong to the hair keratin intermediate filament (krt), 
which are the major structural proteins of hard epithelial tissues, and hair keratin-associated 
protein (krtap) families, specifically involved in differentiation of the HF and or 
sweat/sebaceous glands [19]. Of these, we have listed only the annotated genes encoding 
for known proteins (Table 1) and followed the new consensus nomenclature for mammalian 
keratins as described in Schweizer and coworkers [19]. All identified keratins were either 
hair keratins (type I or II) or epithelial keratins specifically expressed in the HF. Genes 
encoding for hair acidic keratins (type I) mapped on chromosome 11, basic keratins (type 
II) mapped on chromosome 15 whereas krtaps localized on gene clusters mapping in 
chromosomes 11 and 16. KRT and KRTAP families comprise more than 70 different 
proteins which are the main components of hair fibres produced by HFs [20]. KRTAPs are 
essential for the formation of a rigid and resistant hair shaft through their extensive 
disulfide bond cross-linking with abundant cysteine residues of hair keratins. KRTAPs 
include the high-sulfur/ultra-sulfur and the high-glycine-tyrosine proteins, each group 
following a precise spatio-temporal expression pattern in the hair follicle, either in the 
proliferative matrix cells, the cells of the cortex or cuticle. Note that, among the hair keratin 
up-regulated genes (Table 1), krt1-1, krt1-3, krt1-4, krt2-10, krtap8-1 and krtap14 localized 
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to the hair cortex, as previously shown by in situ hybridization. Moreover, all GR-regulated 
hair acidic keratins and most of the krtaps were involved in terminal differentiation of 
follicles in the growth stage or anagenic phase [21, 22]. This relatively high abundance of 
transcripts that are normally expressed in anagenic HFs is most likely due to the fact that 
skin samples used for this microarray analysis were collected from 10-wk old mice 
depilated 48h before, a procedure normally inducing the hair growth stage. 
The identification of several hox genes (hoxa5, hoxa9, hoxc10) as egulated by GR 
(Table 1) deserves particular attention since they constitute the largest group of patterning 
molecules in HF development and cycling and have been involved in transcriptional 
regulation of krtaps (reviewed in [23]). The positive role of GR in HF differentiation was 
further supported by the up-regulation of the signal transduction G-protein coupled receptor 
(Gprc5d) and peptidyl arginine deiminase, type III (Padi3) genes, both expressed in the 
anagen HFs [24, 25]. Altogether, the identification of several hair krts, krtaps and hox as 
GC-regulated genes, among others, strongly suggests a role of GR in HF morphogenesis 
through the coordinated regulation of these hair-specific genes. 
Since GR exerted antiproliferative effects in K5-GR mice, concomitant reduced 
expression of genes related to cell growth was expected. Accordingly, we detected down-
regulation of several immediate early genes, such as fosb and c-fos (Tables 1 and 2), which 
appears as a mechanism for keratinocyte growth inhibition mediated by GR in vivo. 
Moreover, GR negatively regulated other markers known to be involved in regulation of 
cell growth and cell cycle, including cyr61, Ptn, Camk2b and Gdf10. The identified genes 
are candidates to mediate the reported growth inhibitory role of GR in keratinocytes, thus 
contributing to the epidermal hypoplasia exhibited by adult K5-GR mice.  
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Our results confirmed GR-dependent repression of c-fos in vivo and identified fosb 
as a novel gene regulated by GR in skin. Given that fosb was originally identified as an 
immediate early gene and since no specific function has been assigned to FosB in 
keratinocytes so far, we aimed to study whether fosb was specifically regulated by GC 
action in keratinocytes. To this, we examined fosb transcript levels in response to the 
synthetic GC analogue dexamethasone (Dex) in the non-transformed keratinocyte cell line 
PB (Fig. 1). Cells were starved in 0.1% serum for 16h and either left unt eated or treated 
with the indicated concentrations of Dex for 8h before being stimulated with 20% fetal 
bovine serum (FBS) for 30 min. Cells were collected, RNA extracted and fosb transcript 
levels analyzed. As expected, the mRNA corresponding to fosb was induced (3.3-fold) by 
FBS. Dex treatment inhibited this induction in a dose-dependent manner; at 1 µM Dex, fosb 
transcript levels had reached basal levels. In addition, combined treatment of Dex with the 
GR-antagonist Ru486 completely reversed the effect of the ligand, thus reinforcing the idea 
that activated GR negatively regulates fosb (Fig. 1). 
By using a transgenic mouse model of gain-of-function, we have identified novel 
GR-regulated genes in skin, which highlight that GR plays a major role in hair follicle 
differentiation and epidermal homeostasis. These studies may contribute to better 
understand the role of GCs as physiological modulators in this tissue. 
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Discussion  
One of the most relevant findings of this study is that a great percentage of the GR-
regulated genes identified have been previously reported as specifically expressed in the HF 
following a precise spatio-temporally controlled pattern. The mature HF consists of an 
outer root sheath contiguous with the basal layer of the epidermis, an inner root sheath 
serving as the channel from which the hair exits the skin surface, and the hair shaft itself 
[7]. Remarkably, the HF is the only organ in the mammalian body which undergoes cyclic 
transformations and regeneration during its entire life-time. In these periods, a new follicle 
replaces the hair that degenerated and was released, through stages of rapid growth 
(anagen), apoptosis-driven regression (catagen), and quiescence (telogen). It is known that 
different hormones, including GCs, govern growth and development of the HF along with 
the sebaceous and apocrine glands, and the arrector pili muscle, which form the 
pilosebaceous unit (PSU). Recently, it was demonstrated -cultured human scalp 
HFs that PSUs behave as independent peripheral neuro-endocrine organs, resembling the 
hypothalamic-pituitary-adrenal (HPA) axis [26]. These findings constituted a breakthrough 
for understanding how steroid hormon s modulate hair growth and differentiation, even in 
the absence of endocrine, neural, or vascular systemic connections. 
Our data provide evidences at the molecular level supporting a prominent role of 
GR in HF morphogenesis through regulation of numerous hair-specific genes, including 
krts, krtaps and hox family genes (Tables 1 and 2). Given that nearly all members of the 
hox gene family have been described in either skin or hair, or both, in mouse and human, 
the fact that only a subset of hox genes (hoxa5, hoxa9, and hoxc10) is down-regulated in 
K5-GR mice supports a great specificity of GR action in modulating hair development 
through these transcription factors. To date, it is not clear whether or not KRTAP mutations 
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are involved in human hair disorders, although several transgenic mouse models with hair 
defects exhibited changes in their KRTAP gene expression patterns, being Hoxc13 the best 
characterized. Hoxc13 expression was detected in developing hair follicles, tongue and nail, 
all typical regions of hair keratin and possibly KRTAP expression. Interestingly, both 
Hoxc13-deficient mice and Hoxc13-overexpressing mice showed a fragile hair phenotype 
[27, 28]. Microarray analysis revealed that Hoxc13 overexpression resulted in the down-
regulation of a great number of high sulphur and high glycine tyrosine krtap genes, 
including krtap14, krtap15 and several members of the krtap16 family [27]. Remarkably, 
all these genes have also been found differentially expressed in K5-GR mice, as shown in 
Tables 1 and 2, suggesting that they may be useful markers of fragile hair disorders.  
However, additional studies in patients would be necessary to draw any conclusion about 
the role of these genes in human hair disorders. 
It is still a matter of debate whether GR favors or disturbs epidermal barrier 
formation [8]. This is most likely due to the different model systems that have been used to 
approach the issue. Previous evidences supporting that GR accelerate epidermal barrier 
formation come from studies in fetal mouse skin using physiologic concentrations of GCs 
whereas a negative role of GR has been reported in mouse adult skin topically treated with 
pharmacological doses of GCs for a short period [9, 10]. Our transgenic model represents a 
more direct approach to study GR function since the receptor is targeted at proliferating 
basal keratinocytes, from which all epidermis originates, starting at the earlier stages of 
epithelial development (12.5 dpc), before stratification occurs [29]. We previously 
demonstrated that constitutive targeting of GR transgene elicited epidermal hypoplasia and 
reduced HF number at late embryo stages and newborn mice as well as in adult mice [12, 
13]. However, whereas the expression of loricrin, an epidermal marker of terminal 
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differentiation, was increased at the transcript and protein level in K5-GR newborn mice, 
we found no changes in adult individuals (data not shown). These data suggest that GR-
mediated regulation may be differential in the perinatal period versus the adult age. 
Interestingly, the present study has revealed that some genes previously reported to 
be essential in epidermal barrier formation were regulated in the skin of transgenic mice 
overexpressing GR. Among them, there are genes encoding for enzymes with protease or 
anti-protease activity as well as several enzymes involved in steroid and lipid metabolism 
(Table 1). We highlight here 3-hydroxy-3-methylglutaryl-CoA synthase (Hgmcs2), an 
enzyme specifically involved in steroid and lipid biosynthesis and previously described as a 
transcriptional target of GCs in other tissues [30]. Hmgcs2 is a transcriptional target of 
members of the nuclear receptor superfamily PPAR/RXR in the epidermis, as shown by 
various epidermis-specific mouse models [31]. We hypothesize that the positive regulation 
of Hmgcs2 in GR-overexpresing skin would argue in favor of a protective role of GR in 
regulating the epidermal barrier homeostasis. Given the key role of epidermal lipids in 
barrier formation, the identification of the regulatory mechanisms modulating the 
expression of genes involved in lipid biosynthesis is of enormous importance to understand 
the molecular basis of several human skin disorders of keratinization and cornification. 
Collectively, our study approaching the identification of GR-regulated genes in skin 
by using an in vivo model appears as very reliable since we have used complementary 
approaches to the microarray experiment, such as and semi-quantitative PCR and q-RT-
PCR methods. Anyhow, we have found some discrepancies respect to previous reports 
[32], such as the negative -instead of positive- regulation of the dual specificity MAPK 
phosphatase Dusp1 by GR. This is most likely due to cell type differences and, to our 
knowledge, neither the expression pattern of Dusp1 nor its regulation by GCs have been 
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previously described in keratinocytes. Similarly, and despite NF-κB repression has been 
involved in the antiproliferative effect of GCs in other cell types [33], we did not find 
changes in ikbα transcript levels neither in the microarray studies nor by Sq PCR (data not 
shown). Although such a role for NF-κB in keratinocytes can not be ruled out, our data 
strongly support that GR-mediated growth inhibition is partially exerted through 
interference of the hormone receptor with the activator protein (AP)-1 signaling pathway, 
which plays a key role in cell growth, differentiation and oncogenesis in different tissues 
[34]. 
In skin, GR/AP-1 cross-talk is particularly relevant since AP-1 is crucial for many 
processes in skin physiopathology including epithelial development, skin inflammation and 
cancer [35, 36]. The AP-1 family of transcription factors is composed of the fos (c-fos, fosb, 
fra-1, fra-2) and jun (c-jun, junb, junD) gene families. Different hetero- and homo-dimers 
combination is possible to form AP-1 complexes, with which GR physically interacts 
resulting in inhibition of the AP-1 transactivating function [36]. As an additional 
mechanism, GCs also play a role in repressing the action of MAPKs, such as extracellular 
regulated kinase (ERK) and c-Jun N-terminal kinase (JNK), further reducing AP-1 activity. 
Most of the genes belonging to the fos and jun families contain AP-1 binding sites in their 
promoters, therefore, diminished AP-1 transactivation results in their reduced transcription. 
This has been described for c-fos, which is transcriptionally down-regulated by GR through 
GR/AP-1 negative interference in many cell types, including keratinocytes [6]. 
Although the expression of FosB in mouse and human epidermis has been reported 
as undetectable for several groups [32, 37], other reports have shown fosb expression in 
mouse epidermal tissue [38]. Our results suggest that c-fos and fosb are dispensable for the 
Page 17 of 32 
Ac
ce
pte
d M
an
us
cri
pt
 18
expression of terminal differentiation-associated proteins and the maintenance of 
differentiation in K5-GR mice, in agreement with the lack of skin phenotype of c-fos- and 
fosb-deficient mice (reviewed in [39]). However, c-fos plays a determinant role in skin 
responses such as tumor progression as the absence of c-fos caused malignant conversion 
of skin tumors [40]. Contrary to c-fos, c-jun transcript was induced by Dex in wt and 
GRdim mouse skin, likely mediated by the DNA-binding independent function of GR on 
Jun/Jun homodimers [6]. We did not find variation in the levels of c-jun in K5-GR skin as 
compared to wt mice (not shown). Since c-Jun is continuously available whereas c-Fos and 
FosB are decreased in GR-overexpressing skin, formation of Jun/Fos heterodimers, the 
most potent activators, is unfavored. That implies that other AP-1 complexes, such as Jun 
homodimers are more feasible and might differentially regulate another subset of AP-1- 
target genes. This might be an explanation for the observed up-regulation of matrix 
metalloproteinase (MMP)-11/stromelysin-3 (Table 1), which contains AP-1 binding sites in 
its promoter. It has been reported that its positive regulation is mediated through increased 
Jun expression and binding of Jun/AP-1 complexes [32]. 
Our previous work has shown that GR overexpression strikingly altered epidermal 
and HF development [12, 13]. By using a genomic approach, we here report the 
identification of numerous genes crucial in epidermal homeostasis and HF morphogenesis 
as GR-regulated genes. Our findings may contribute to elucidate the precise mechanisms by 
which GC hormones modulate skin physiopathology. 
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Table and Figure legends 
Table 1. Classification of up- and down-regulated genes in transgenic skin overexpresing 
GR by functional categories (n= 173). The 173 genes induced or repressed 1.4-fold or 
greater by GC were categorized based on protein function; however, many of these genes 
likely fit into more than one category.  
 
Table 2. Quantitation of several genes up- and down-regulated in transgenic skin 
overexpresing GR vs. wt obtained by microarray analysis, by semi-quantitative PCR (Sq 
PCR) and quantitative real-time PCR (q-RT-PCR). RNA was obtained from WT and K5-
GR skin in an independent experiment and Sq PCR and qRT-PCR were performed as 
indicated under Materials and Methods. Mean value of duplicates is shown in all cases. (1) 
For Sq PCR, specific oligonucleotides corresponding to the indicated genes were used and 
normalized to β-actin levels. (2) For q-RT-PCR, indicated transcript levels were quantitated 
using two housekeeping genes and expressed as a ratio of 
(gene/housekeeping)transgenic/(gene/housekeeping)wt. nd means not determined. 
 
Fig. 1. Regulation of fosb by activated GR. Cultured cells of the non-transformed 
keratinocyte line PB were starved in 0,1% serum for 16h and either left untreated or treated 
with Dex (10 nM or 1µM) for 8h or Dex 1µM plus the GR antagonist Ru486 (10 µM) 
before being stimulated with 20% serum for 30 min. Cells were collected, RNA extracted 
and fosb transcript levels analyzed. Basal transcript levels of fosb were arbitrarily set as 1 
and values expressed as relative to untreated cells. 
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Donet et al., Table 1 (I). Classification of up- and down-regulated genes in transgenic skin overexpresing GR
by functional categories (n= 173). 
Genbank Description/Annotation Gene symbol/Alias Fold-change
Cytoskeleton organization and biogenesis
NM_010666 keratin complex-1, acidic, gene C29/keratin 27 krt1-c29/krt27 3.09
AK01464 4733401L19Rik krt28 1.8
NM 010659 k ti l 1 idi 1 k t1 1/H 1/k t31 2 04_  era n comp ex , ac c, gene r - a r  .
NM_027983 keratin complex 1, acidic, gene 3 krt1-3/Ha3/Ha4/krt33a 2.02
NM_027563 keratin complex 1, acidic, gene 4 krt1-4/Ha2/krt342.99
NM_016880 keratin complex 1, acidic, gene 24 krt1-24/Ha5/krt35 1.93
NM_008476 keratin complex 2, basic, gene 6a krt2-6a/mK6a/krt6a 1.41
NM 019956 keratin complex 2, basic, gene 6g krt2-6g/mK6irs/krt71 3.08_      
NM_212485 type II keratin Kb36 kb36/krt73 3.24
AF312018 keratin complex 2, basic, gene 19 krt2-19/krt81 1.56
X99143 keratin complex 2, basic, gene 10 krt2-10/MHb4/krt86 2.74
NM_016879 keratin complex 2, basic, gene 18 krt2-18/Hb5/krt85 2.74
AK017442 keratin associated protein 2-4 krtap2-4 3.48
BC060278 keratin associated protein 3-1 krtap3-1 2.29
NM_025524 keratin associated protein 3-3 krtap3-3 4.43
NM_001037822 keratin associated protein 5-5 krtap5-5 1.48
NM_010672 keratin associated protein 6-1 krtap6-1/HGTpII.1, HGTpII.2 4.1
NM_010673 keratin associated protein 6-2 krtap6-2/HGTpII.4 2.51
D89901 keratin associated protein 6-3 krtap6-3/HGTpII.3 3.01
AA727386 keratin associated protein 8-1 krtap8-1 4 41   .
NM_010676 keratin associated protein 8-2 krtap8-2/HGTpI alpha 1.82
NM_015741 keratin associated protein 9-1 krtap9-1 2.44
NM_183189 keratin associated protein 13-1 krtap13-1 1.66
NM_013707 keratin associated protein 14 krtap14/Pmg-1/mKAP13 2.53
NM_013713 keratin associated protein 15 krtap15/Pmg-2 5.08
NM_130872 AF345293 keratin associated protein 16-3 krtap16-3 1.87
AV294513 keratin associated protein 16-6 krtap16-6 2.61
NM_130875 keratin associated protein 16-7 krtap16-7 2.28
AF345298 keratin associated protein 16-8 krtap16-8 4.25
NM_010855 myosin, heavy polipeptide 4, skeletal muscle Myh4 1.5
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Donet et al.,Table 1 (II)
Up-regulated genes
Genbank Description/Annotation Gene symbol/Alias Fold-change
Cell growth, differentiation and adhesion
NM_008606 matrix metalloproteinase 11 Mmp11 1.69
AK017438 RIKEN cDNA 5530401N06 gene 5530401N06Rik               1.62
NM_008125 gap junction membrane channel protein beta 2 Gjb2 1.56
NM 009263 secreted phosphoprotein 1 Spp1 1 47_    .
NM_007400 a disintegrin and metallopeptidase domain 12 Adam12 1.4
Development/morphogenesis
NM_010923 neuronatin Nnat                                   2.48
NM_016669 crystallin, mu Crym 1.77
Lipid metabolism
NM_053080 aldehyde dehydrogenase family 1, subfamily A3 Aldh1a3 1.71
NM_011044 phosphoenolpyruvate carboxykinase 1, cytosolic Pck1 1.67
NM_008256 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 2 Hmgcs2 1.65
NM_010174 fatty acid binding protein 3, muscle and heart Fabp3 1.56
NM_009605 adiponectin, C1Q and collagen domain containing Adipoq 1.56
Immune and defense response
NM_153108 beta defensin 8 Defb8 3.07
NM_152839 immunoglobulin joining chain Igj 1.54
NM_011315 serum amyloid A 3 Saa3 1.42
Signal transduction 
NM_053118 G protein-coupled receptor, family C, group 5,
member D Gprc5d 1.87
Apoptosis
NM_020581 angiopoietin-like 4 Angptl4 1.67
NM_207680 BCL2-like 11 (apoptosis facilitator) Bcl2l11 1.46
Miscellaneous
NM_011310 S100 calcium binding protein A3 S100a3 2.8
NM_009532 X-ray repair complementing defective repair
in Chinese hamster cells 1 Xrcc1 1.95
NM_009984 cathepsin L Ctsl 1.43
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Down-regulated genes
Genbank Description/Annotation Gene symbol/Alias Fold-change
Cytoskeleton organization and biogenesis
Donet et al.,Table 1 (III)
NM_080285 cortactin binding protein 2 Cttnbp2 1.62
AK029836 myosin IXa 4732465J09Rik 1.46
Cell growth, differentiation and adhesion
NM_008036 FBJ osteosarcoma oncogene B fosb 2.30
NM_010516 BB533736 cysteine rich protein 61 cyr61 2.23
NM 177259 di bl d h l 1 (D hil ) D b1 1 72_ sa e  omo og  rosop a a .
NM_008973 pleiotrophin Ptn 1.59
NM_007595 Calcium/calmodulin-dependent protein kinase II, beta Camk2b 1.58
NM_176930 RIKEN cDNA C130076O07 gene C130076O07Rik 1.57
NM_145741 growth differentiation factor 10 Gdf10 1.55
NM_010234 AV026617 FBJ osteosarcoma oncogene fos 1.46
NM 013642 dual specificity phosphatase 1 Dusp1 1 42_    .
Development/morphogenesis
NM_010456 AA98718 homeo box A9 Hoxa9 1.8
NM_010462 homeo box C10 Hoxc10 1.77
NM_013869 Tumor necrosis factor receptor superfamily, member 19 Tnfrsf19 1.58
NM_013834 secreted frizzled-related sequence protein 1 Sfrp1 1.48
NM_010453 homeo box A5 Hoxa5 1.47
NM_028882 sema domain, immunoglobulin domain (Ig),
short basic domain, secreted, (semaphorin) 3D Sema3d 1.46
Lipid metabolism
NM_024450 BE133651 stearoyl-coenzyme A desaturase 3 Scd3 1.85
NM_001004146 RIKEN cDNA 4933439C20 gene 4933439C20Rik 1.64
NM_001042451 synuclein, alpha Snca 1.57 
NM 146006 lanosterol synthase Lss 1 52_   .
NM_001033599 acyl-CoA synthetase long-chain family member 6 Acsl6 1.49
Immune and defense response
NM_183257 hepcidin antimicrobial peptide 2 Hamp2 1.88
NM_009244 serine (or cysteine) peptidase inhibitor,
clade A, member 1b Serpina 1b 1.53
Signal transduction
NM_008137 guanine nucleotide binding protein, alpha 14 Gna14 1.57
NM_022420 BC02000 G protein-coupled receptor, family C, group 5,
member B Gprc5b 1.62
Apoptosis
NM_007870 deoxyribonuclease 1-like 3 Dnase1l3 1.87
NM_153407 cDNA sequence BC035295 BC035295 1.49
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ptDonet et al., Table 2. Quantitation of several genes up- and down-regulatedin transgenic skin overexpresing GR vs wt obtained by microarray analysis     .    
Fold-regulation microarrays data   Sq PCR (1) q-RT-PCR (2)
Up regulated genes-
krtap14 2,41 2,0 nd
krtap16-7 2,22 2,6 nd
krtap16-8 4,37 3,3 nd
Gprc5d 1,90 3,4 nd
krt2-10 4,36 4,9 31
S100a3 2,75 1,4 3,0
Down-regulated genes
c-fos 1,63 nd 2,9
fosb 2,30 3,2 6,1
cyr61 2,25 1,4 1,7
(1) Sq PCR, semi-quantitative PCR; (2) q-RT-PCR, quantitative real-time PCR;
nd, not determined
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